From Signal to Score:

The EMCR Score™ Explained

HeartForce’s Electro-mechanical CAD Response Score (EMCR Score™) is a proprietary algorithm that converts SCG signals into a clear, reliable assessment of CAD risk. It brings together:

  • 3D SCG waveform data
  • Clinical risk factors (age, sex, hypertension, diabetes, dyslipidemia, smoking, family history)
  • Symptoms such as chest pain or shortness of breath

The EMCR Score™ estimates the likelihood that a patient has coronary artery disease, defined as more than 50% blockage in at least one coronary artery. It is calculated by combining seismocardiogram (SCG) data with key risk factors and reported symptoms.

Our AI algorithm analyzes this data to classify individuals into very low, low, medium, high or very high CAD-risk categories.

Clinical Significance of the EMCR Score™

Early Stage Assessment

Helps identify patients at risk of CAD, even before symptoms emerge.

Risk Stratification

Supports physicians in identifying patients who require advanced diagnostic imaging, such as CCTA or ICA.

High-Risk Screening

Fills a critical gap in current diagnostic workflows by revealing CAD in high-risk patients with multiple CAD-associated risk factors.

What our Risk Categories Mean for Clinical Action

Based on clinical research and the latest recommended guidelines (“2024 ESC guidelines for the management of chronic coronary syndromes”), the EMCR Score™ was divided into five categories to aid clinical interpretation:

EMCR Score risk gauge

Very Low Risk (EMCR < 0.05):

This range indicates a very low prevalence of significant CAD (less than 5%).

Low Risk (EMCR between 0.05 and 0.15):

This range indicates a low prevalence of significant CAD (between 5% and 15%). For such patients, physicians may reasonably defer further diagnostic testing, while considering the overall clinical context.

Intermediate Risk (EMCR between 0.15 and 0.50):

This range suggests the need for further clinical evaluation through non-invasive measures such as Coronary Computed Tomography Angiography (CCTA) medical imaging. Expected prevalence between (15% and 50%).

High Risk (EMCR between 0.50 and 0.85):

This category indicates a high prevalence of significant CAD (between 50% and 85%). Further clinical measures, such as Invasive Coronary Angiography (ICA) or CCTA medical imaging, are suggested.

Very High Risk (EMCR > 0.85):

This category indicates a high prevalence of significant CAD (greater than 85%). Further clinical measures, such as ICA, are suggested.

What You Get

Instant CAD risk stratification (very low, low, moderate, high, and very high)

Objective, evidence-based support for referral or further diagnostics

No imaging, radiation, or specialized staff required

While final diagnostic decisions remain with the healthcare professional, the EMCR Score™ adds a powerful layer of objective insight that strengthens confidence in triage and follow-up decisions.

You are leaving the US website

You are leaving the US version of the HeartForce website and entering our global website.

Product availability, regulatory status, risk categorisation, and performance claims may differ between regions and may not apply to the United States.

CardioClin™ is not cleared or approved by the U.S. Food and Drug Administration (FDA).

Please return to the US website for information applicable to the United States.